Zinc Oxide
| Evidence Level: L4 | Predicted Indications: 5 |
Table of Contents
Zinc Oxide: Acne (disease)
One-Sentence Summary
Zinc oxide is a topical skin protectant, originally used for skin conditions such as tinea infections, dermatitis, rash, burns, hemorrhoids and proctitis. The TxGNN model predicts it may be effective for acne (disease), but there are currently no registered clinical trials and only 3 indirect publications behind this prediction, so it should be treated as a research question rather than an established use.
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded in the local data |
| Predicted New Indication | Acne (disease) |
| TxGNN Prediction Score | 0.9986 |
| Evidence Level | L4 |
| India Market Status | Listed in a compiled Indian medicine price dataset (4 of 4) – CDSCO approval status is not included in this data |
| Number of Listed Products | 4 (valid: 4) |
| Recommended Decision | Hold |
Why is This Prediction Reasonable?
Currently, detailed mechanism of action data is not available. Based on known information, zinc oxide is a topical skin-protective and mild antimicrobial agent. It is already used for inflammatory and infective skin conditions, and mechanistically it may be applicable to acne.
Zinc has plausible anti-acne activity: antibacterial effects against Cutibacterium acnes, anti-inflammatory action, and modulation of sebum. Zinc oxide is also a known antimicrobial and skin-protective agent in topical and nanoparticle formulations. Acne is an inflammatory skin disease involving bacteria, so it is biologically close to the dermatitis and skin-infection indications the drug already covers.
The available evidence is indirect and does not establish clinical efficacy of zinc oxide itself for acne. The high TxGNN score is consistent with the biological plausibility, but it is a computational prediction only.
Clinical Trial Evidence
Currently no related clinical trials registered.
Literature Evidence
| PMID | Year | Type | Journal | Key Findings |
|---|---|---|---|---|
| 15536660 | 2004 | Clinical study (split-face assessment) | Skin Research and Technology | Split-face clinical and bioinstrumental assessment in mild inflammatory catamenial acne; the available abstract does not give results specific to zinc oxide |
| 21342155 | 2011 | Review | International Journal of Dermatology | Nanoparticles such as zinc oxide and titanium dioxide have unique properties; nano-preparations are under investigation for acne vulgaris, atopic dermatitis and other skin conditions |
| 36888703 | 2023 | Preclinical (microneedle study) | Science Advances | Ultrasound-responsive zinc porphyrin-based nanoparticle microneedle patch for bacterial acne; a materials study, not zinc oxide itself |
India Market Information
| Authorization Number | Product Name | Dosage Form | Approved Indication |
|---|---|---|---|
| 200795 | Sunheal Pure Cream | Tube of 30 gm cream | Not specified |
| 200407 | Suncros Soft 2% Cream | Tube of 50 gm cream | Not specified |
| 185015 | Rashcare Cream | Tube of 20 gm cream | Not specified |
| 200312 | Sofirash Cream | Tube of 30 gm cream | Not specified |
All four licences are valid single-ingredient topical creams.
Safety Considerations
- Disease associations flagged in the knowledge graph (not label text): The knowledge graph links zinc oxide to contraindication-type relationships with several conditions, including hypertension, benign prostatic hyperplasia, sickle cell anemia, primary hyperoxaluria, hereditary hemochromatosis and other iron metabolism disorders, Wilson disease, coronary artery disease, heart conduction disease, hyperthyroidism and anxiety. These are model-level associations, likely reflecting systemic zinc rather than topical use, and should be verified against the product labels.
Please refer to the package insert for further safety information.
Conclusion and Next Steps
Decision: Hold
Rationale: The acne prediction rests on biological plausibility and indirect literature only. There are no clinical trials, and the three publications do not show that zinc oxide itself is effective for acne. The other four ranked predictions (anorectal stricture, anal polyp, papillary conjunctivitis, postinfectious vasculitis) have no trials, no literature and no supporting mechanism, so they are weaker still.
To proceed, the following is needed:
- Package insert warnings and contraindications for the marketed Indian products, which are required before safety screening
- Detailed mechanism of action data
- Direct preclinical or clinical data on topical zinc oxide in acne, for example a controlled trial against a standard topical comparator
- Review of the knowledge graph contraindication associations against the topical labels
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.